IN BRIEF / Southland

ChromaVision Medical Systems Inc., a San Juan Capistrano manufacturer of automated cell-imaging systems, said Wednesday that it has obtained $12.5 million in additional funding through the sale of preferred stock and warrants to a private investor group.

The company said in a news release that the group is headed by Halifax Fund LP, which is managed by The Palladin Group, and that other investors include Safeguard Scientifics, currently ChromaVision’s largest shareholder.

ChromaVision said it will use the proceeds to spur sales growth and to provide general corporate funding.